COVID-19 and kidney disease: A deadly intersection that requires investment in prevention, research
June 23, 2020
In the months since the novel coronavirus first began infecting individuals in the United States, Americans – health care professionals, researchers, and the public alike – have received a rapid and ever-changing education in the medical science on this devasting virus.
What we initially understood as primarily a respiratory illness has proven itself to be much more.
It’s a virus that can devastate the lungs, but we’ve learned that it can also cause significant injury to other vital organs including the kidneys. Among the most troubling realities is that the virus poses a disproportionate risk to a population of Americans whose health and health care is already so fragile: those living with kidney disease and kidney failure, as well as those living with kidney transplants who rely on immunosuppressant medications which depress the body’s ability to counter infection.